Faeth Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Faeth Therapeutics, Inc. (FTH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.6% of the shares are freely tradable; institutional investors hold 25.9%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vivo Capital, LLC | 2.79 | 722,020 | +0.0 | 06/30/2026 |
| Logos Global Management LP | 2.79 | 722,020 | +2,306.7 | 06/30/2026 |
| Caligan Partners LP | 2.44 | 629,467 | +399.6 | 06/30/2026 |
| Trails Edge Capital Partners, LP | 1.99 | 515,335 | +312.3 | 06/30/2026 |
| Octagon Capital Advisors LP | 1.40 | 361,010 | +0.0 | 06/30/2026 |
| Cormorant Asset Management, LLC | 1.19 | 306,222 | +0.0 | 03/31/2026 |
| StemPoint Capital LP | 1.03 | 265,746 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Polar Capital Biotech S Inc | 3.82 | 986,890 | +0.0 | 07/31/2026 |
| Franklin Biotechnology Discv A(acc)USD | 1.30 | 337,086 | +7.4 | 07/31/2026 |
| Franklin Biotechnology Discovery A | 0.70 | 180,711 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.